This innovative R&D project is focused on the new technological dimension for the antibacterial and osseointegrated coatings. The CarLa project is connected with the topic of materials science and engineering (design of new interfaces, surfaces and coatings in form of Ag/Si doped DLC) including usage of nanotechnologies and production processes for coatings fabrication. Apart from the technological part, project consists also of coatings’ characterization and mechanical properties estimation. Project predicts also the industrial partners (SMEs) and commercialization of the results that is why it also includes the third part of research – biological tests. That consists of its multidisciplinary character. The aim of the project is to solve the global problem of society and medicine on the whole world. Through that project inscribes to the strategic aim of the M-ERA.NET Programme – increases interdisciplinary cooperation in order to create a powerful network to tackle European and global challenges – in this case post-implantation complications which are caused by the infections and/or allergy induced by alloying elements. The expected results of this project will cover elaboration of Ag/Si doped carbon coatings, their mechanical verification, biological evaluation and testing under industrial conditions in order to introduce to the market the new safe product with satisfying osseointegration, antimicrobial and mechanical properties.The results of the CarLa Project are expected to be for the big benefit of the European industry and society. The industry will get an ecological, simply, cheap and easy to implement technology in favor of healthier society – the offer of biomaterials with better properties giving faster healing processes for patients and lower risk of infection during and after implantation. Trough that it fulfills the efforts of new innovation oriented economy in EU.
Thanks to the technologies, which will be worked out in the frame of this project, new markets will be opened not only for these represented by the industry partners (dentistry and orthopedic) within the confines of the project consortium. We also expect that technologies we are going to apply will have a wide range of potential to be used in many branches of industry, also apart from these provided by the SME partners. The cooperation in the frame of transnational consortium give us a chance to exploit international technology and market expertise.